PCM
ORGS

Prelude Capital Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Prelude Capital Management’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-272
Closed -$17K – 2470
2020
Q2 		$17K Buy
+272
New +$16.5K ﹤0.01% 1430

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Prelude Capital Management's ORGS Position: Q3 2020 in Review

Prelude Capital Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2020, closing a stake of 272 shares — an estimated $17K sold.

Prelude Capital Management first reported a position in ORGS in Q2 2020 and held it in 1 quarter. The position peaked at $17K in Q2 2020. 39 funds tracked by Wall St. Rank hold ORGS as of Q3 2020.

  • Prelude Capital Management reported no remaining Orgenesis Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 272 Orgenesis Inc. Common Stock shares in Q3 2020, an estimated $17K.
  • Prelude Capital Management first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Prelude Capital Management's Orgenesis Inc. Common Stock position peaked at $17K in Q2 2020.
  • 39 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.